What the evidence says. Graded mixed: meta-analyses in adults over 50 show small but real gains in lean mass and grip/function, yet in young trained subjects pooled trials find no effect on body composition or strength — so the benefit is population-dependent and modest, not the broad muscle-builder it's marketed as. (Mixed evidence: Conflicting results across studies; benefit uncertain.)
What is HMB?
HMB (β-Hydroxy β-Methylbutyrate) is a performance supplement used for preserve muscle in aging. NutriDex grades the human evidence as Mixed. HMB is a metabolite of the amino acid leucine, sold to build muscle and speed recovery. The evidence splits sharply by population. In adults over 50, several meta-analyses find modest but consistent benefits: fat-free mass rises by roughly 0.3–0.4 standardized units (about 0.3 kg of lean mass, up to ~1.5 kg appendicular muscle in the largest 2025 pooling), with small improvements in grip strength and chair-stand time, typically needing 3 g/day for 12+ weeks. In young, resistance-trained adults the picture is different — a 2020 meta-analysis of 11 RCTs found no significant effect on body composition or strength. Benefits appear concentrated in anti-catabolic settings (aging, sarcopenia, bed rest, clinical wasting) rather than muscle-building in healthy athletes. Effect sizes are small and several trials are industry-linked, so expectations should stay measured.
Purported Benefits
✓Preserve muscle in aging
✓Slow muscle wasting
✓Modest lean-mass gains (older adults)
✓Reduce muscle-damage markers
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
HMB is well tolerated: human trials and reviews report no serious adverse effects at up to 3 g/day, and no negative impact on blood glucose, insulin sensitivity, lipids, or liver and kidney markers. Mild GI complaints (nausea, heartburn, flatulence) are the main reported issues. There are no well-established drug interactions, but data in pregnancy, breastfeeding, and children are lacking, so it is not recommended for them; anyone with kidney or liver disease should consult a clinician before use. Educational only — always check with your doctor or pharmacist before combining HMB with any medicine.
HMB is most often taken for Preserve muscle in aging, Slow muscle wasting, Modest lean-mass gains (older adults), Reduce muscle-damage markers. Leucine metabolite — preserves muscle in aging, not in young lifters.
Does HMB work — what does the evidence say?
Mixed evidence. Conflicting results across studies; benefit uncertain. HMB is a metabolite of the amino acid leucine, sold to build muscle and speed recovery. The evidence splits sharply by population. In adults over 50, several meta-analyses find modest but consistent benefits: fat-free mass rises by roughly 0.3–0.4 standardized units (about 0.3 kg of lean mass, up to ~1.5 kg appendicular muscle in the largest 2025 pooling), with small improvements in grip strength and chair-stand time, typically needing 3 g/day for 12+ weeks. In young, resistance-trained adults the picture is different — a 2020 meta-analysis of 11 RCTs found no significant effect on body composition or strength. Benefits appear concentrated in anti-catabolic settings (aging, sarcopenia, bed rest, clinical wasting) rather than muscle-building in healthy athletes. Effect sizes are small and several trials are industry-linked, so expectations should stay measured.
What is the typical dose of HMB?
3 g/day, usually split into 1 g doses with meals; HMB-Ca and free-acid forms perform similarly, with effects most likely after 12+ weeks.
Is HMB safe? Any cautions or side effects?
HMB is well tolerated: human trials and reviews report no serious adverse effects at up to 3 g/day, and no negative impact on blood glucose, insulin sensitivity, lipids, or liver and kidney markers. Mild GI complaints (nausea, heartburn, flatulence) are the main reported issues. There are no well-established drug interactions, but data in pregnancy, breastfeeding, and children are lacking, so it is not recommended for them; anyone with kidney or liver disease should consult a clinician before use.
How many studies support HMB?
NutriDex cites 9 sources for HMB, graded "Mixed".
Cite this page
APA
Peh, D. (2026). HMB (β-Hydroxy β-Methylbutyrate): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/hmb
BibTeX
@misc{nutridex_hmb,
author = {Peh, Daryl},
title = {HMB (β-Hydroxy β-Methylbutyrate): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/hmb},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.